Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005; 40:951-958. Available

Strathdee SA, Latka M, Campbell J, O'Driscoll T, Golub ET, Kapadia F, Pollini RA, Garfien RS, Thomas DL, and Hagen H. Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. For the Study to Reduce Intravenous Exposures Project. Clin Infect Dis. 2005; 40(Suppl 5):S304-312. Available

Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005; 79(3):389-395. Available

Gershon RR, Mitchell C, Sherman MF, Vlahov D, Lears MK, Felknor S, Lubelczyk RA. Hepatitis B vaccination in correctional health care workers. Am J Infect Control. 2005; 33(9):510-18.

Mehta SH, Thomas DL, Sulkowski MS, Sagaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drugs users. AIDS. 2005; 19 Suppl 3:S179-S189.

2004 Publications

Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. Journal of Clinical Virology. 2004; 31:210-214. Available

Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004; 39(1):51-7.

Garten RJ, Lai S, Zhange J, Liu W, Chen J, Vlahov D, Yu XF. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology. 2004; 33(1):182-8. Available

Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence-a comparison between injection and noninjection drug users in New York City. Journal of Urban Health. 2004; 81(1):20-24. Available

Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes and Immunity. 2004; 5(4):261-6.

Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brein S, Astemborski J, Thomas DL. An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes and Immunity. 2004; 5(4):294-300.

Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health. 2004; 94(7):1218-23. Available

Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astermborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004; 305(5685):872-4. Available

Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J, Thomas DL. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus injection. Journal of Virology. 2004; 78:11258-11262. Available

2003 Publications

Des Jarlais, DC,...Diaz T,...Vlahov D,...Latka M,...Edwards V.... Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology. 2003; 157(5):467-71. Available

Koblin B, Factor SH, Wu Y, Vlahov D. Hepatitis C virus infection among non-injecting drug users in New York City. Journal of Medical Virology. 2003; 70(3):387-90.

Zwahlen M, Vlahov D. Commentary: modeling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users. International Journal of Epidemiology. 2003; 32(5):715-6. Available

2002 Publications

Thio CL,...Vlahov D, et al.. Racial differences in HLA class II associations with hepatitis C virus outcomes. Journal of Infectious Diseases. 2002; 185(2):266-8. Available

Mehta SH,...Vlahov D et al.. Protection against persistence of hepatitis C. Lancet. 2002; 359(9316):1478-83. Available

Thio CL,...Vlahov D et al.. HLA-Cw*04 and hepatitis C virus persistence. Journal of Virology. 2002; 76(10):4792-7. Available

Rai R,...Vlahov D et al.. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology. 2002; 35(5):1247-55. Available

Ompad DC, Fuller CM, Vlahov D, et al.. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases. 2002; 35(7):783-8. Available

2001 Publications

Diaz T,... Vlahov D,... Edwards V, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health. 2001; 91(1):23-30. Available

Mao Q,...Vlahov D, et al. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. Journal of Virology. 2001; 75(7):3259-67. Available

Sadaphal P,... Vlahov D, et al. Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clinical Infectious Diseases. 2001; 33(10):1687-91. Available

2000 Publications

Thio CL,... Vlahov D, et al. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. Journal of Clinical Microbiology. 2000; 38(2):575-7.

Thomas DL,... Vlahov D, et al. Determinants of the quantity of hepatitis C virus RNA. Journal of Infectious Diseases. 2000; 181(3):844-51. Available

Thomas DL,... Vlahov D, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA: the Journal of the American Medical Association. 2000; 284(4):450-6. Available

Thomas DL,... Vlahov D, et al. Long-term prognosis of hepatitis c virus infection. JAMA: the Journal of the American Medical Association. 2000; 284(2):2592. Available

1999 Publications

Inglesby TV,... Vlahov D, et al. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology. 1999; 29(2):590-6. Available

Villano SA, Vlahov D, Nelson KE, Kohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999; 29(3):908-14. Available

Thio CL,... Vlahov D, et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. Journal of Infectious Diseases. 1999; 179(4):1004-6. Available

Note: Bibliographic citations are received directly from the authors and may not reflect the exact citations of the actual published works.